Litcius/Paper detail

Corticosteroids in Patients With COVID-19: What About the Control Group?

Tomasz Chroboczek, Marie Lacoste, C. Wackenheim, T. Challan-Belval, Benjamin Amar, Thomas Boisson, Jason Hubac, Dominique Leduc, C Massé, Victor Dechaene, Laetitia Touihri-Maximin, Sandrine Mégessier, Camille Lassale

2020Clinical Infectious Diseases14 citationsDOIOpen Access PDF

Abstract

65 000 confirmed SARS-CoV-2 cases. We encourage others to perform similar serosurveys periodically and in other regions to allow proper comparisons of dynamics at distinct sites and the impact of preventive measures.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineGroup (periodic table)VirologyInternal medicineOutbreakChemistryDiseaseInfectious disease (medical specialty)Organic chemistryCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Thermal Regulation in Medicine
Corticosteroids in Patients With COVID-19: What About the Control Group? | Litcius